Merck jumps on strong quarterly results
Shares of pharma co Merck Ltd climbed as much as 5.1 per cent to Rs 1,520 on strong results. The stock posted its biggest intraday percentage gain since February 12. IDBI Capital has raise23-02-2018
23-02-2018
Board recommends Dividend
Merck Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 22, 2018, inter alia, has recommended payment of dividend at the rate of Rs. 15/- (Rupees Fifteen only) per equity share of Rs. 10/- each for the year ended December 31, 2017.22-02-2018
Board Meeting-Outcome of Board Meeting
The Board at its meeting held today, February 22, 2018 has approved the Audited Financial Results for the quarter and year ended December 31, 2017, copy of the same along with Audit Report and declaration in respect of Audit Report with unmodified opinion for the year ended December 31, 2017 are enclosed herewith. The Audited Financial Results will be published in the newspapers within the stipulated time as...22-02-2018
Board to consider Dividend
Merck Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 22, 2018, inter alia, to consider and approve the audited financial results for the year ended December 31, 2017 and to consider recommendation of dividend for the year 2017.06-02-2018
Board Meeting On Thursday, 22 February 2018.
06 February 2018 National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Bandra - Kurla Complex 1st Floor, Rotunda Building, Dalal Mumbai 400 051 Street, Fort, Mumbai 400 001 Dear Sir/Madam, Sub: Notice of the Board Meeting In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 we wish to inform you that a meeting of...06-02-2018
Board Meeting On Thursday, 22 February 2018.
06 February 2018 National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Bandra - Kurla Complex 1st Floor, Rotunda Building, Dalal Mumbai 400 051 Street, Fort, Mumbai 400 001 Dear Sir/Madam, Sub: Notice of the Board Meeting In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 we wish to inform you that a meeting of...06-02-2018
Shareholding for the Period Ended December 31, 2017
Merck Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here19-01-2018
Compliance Certificate For The Year Ended 31 December 2017
Subject: Compliance Certificate as per Reg. 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the above we are enclosing herewith compliance certificate as per Reg. 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the period ended 31st December 2017....18-01-2018
Compliance Certificate For The Year Ended 31 December 2017
Subject: Compliance Certificate as per Reg. 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the above we are enclosing herewith compliance certificate as per Reg. 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the period ended 31st December 2017....18-01-2018